These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7063110)

  • 21. Opposite effects of intranigral ibotenic acid and 6-hydroxydopamine on motor behavior and on striatal neuropeptide Y neurons.
    Nitsch C; Wolfrum G; Schaefer F; Scotti AL; Unger J
    Brain Res Bull; 1993; 30(1-2):21-32. PubMed ID: 8420631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian activity, nociceptive thresholds, nigrostriatal and mesolimbic dopaminergic activity in the Naples High- and Low-Excitability rat lines.
    Sadile AG; Lamberti C; Siegfried B; Welzl H
    Behav Brain Res; 1993 May; 55(1):17-27. PubMed ID: 8101085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel black-hooded mutant rat (ci3) with spontaneous circling behavior but normal auditory and vestibular functions.
    Lessenich A; Lindemann S; Richter A; Hedrich HJ; Wedekind D; Kaiser A; Löscher W
    Neuroscience; 2001; 107(4):615-28. PubMed ID: 11720785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function.
    Hirsch SR; Richardson-Andrews R; Costall B; Kelly ME; de Belleroche J; Naylor RJ
    Psychopharmacology (Berl); 1987; 93(1):101-4. PubMed ID: 2819921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-accumbens implants of embryonic dopaminergic neurons reverse the behavioral supersensitivity to opiates evoked by lesion of the mesolimbic dopaminergic pathway.
    Abrous DN; Stinus L; Le Moal M; Herman JP
    Brain Res; 1990 Aug; 525(1):155-9. PubMed ID: 2245321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1982 Apr; 21(4):327-35. PubMed ID: 7201088
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of apomorphine on behavioural activity and brain catecholamine synthesis in normal and L-triiodothyronine-treated rats.
    Rastogi RB; Singhal RL; Lapierre YD
    J Neural Transm; 1981; 50(2-4):139-48. PubMed ID: 7241114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity.
    Jones GH; Robbins TW
    Pharmacol Biochem Behav; 1992 Nov; 43(3):887-95. PubMed ID: 1448483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance P modulation of the mesolimbic dopamine system.
    Kalivas P
    Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Carey RJ
    Exp Neurol; 1986 Jun; 92(3):591-600. PubMed ID: 3086112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior.
    Richter A; Ebert U; Nobrega JN; Vallbacka JJ; Fedrowitz M; Löscher W
    Neuroscience; 1999 Mar; 89(2):461-71. PubMed ID: 10077328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
    Kalivas PW
    J Pharmacol Exp Ther; 1985 Nov; 235(2):544-50. PubMed ID: 4057084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyper-reactivity to amphetamine in rats with dopaminergic grafts.
    Herman JP; Choulli K; Le Moal M
    Exp Brain Res; 1985; 60(3):521-6. PubMed ID: 4076374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypophysectomy-induced striatal hypersensitivity and mesolimbic hyposensitivity to apomorphine.
    Gordon JH
    Pharmacol Biochem Behav; 1983 Nov; 19(5):807-11. PubMed ID: 6139829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.